{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:36:00Z","timestamp":1791380160487,"version":"4.3.3"},"reference-count":24,"publisher":"MedWorks Media","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Background: Tramadol is a widely used analgesic with a unique dual mechanism of action, combining weak \u03bc-opioid receptor agonism with inhibition of norepinephrine and serotonin reuptake. It is frequently prescribed for various acute and chronic pain conditions. Evaluating prescribing trends can provide valuable insight into clinical practice patterns and inform institutional pain management strategies and policy development. Objective: To assess tramadol prescribing patterns over a one-year period in a university-based health system and compare them to overall opioid prescribing. Methods: A retrospective review was conducted using electronic medical record (EMR) data from January 1, 2024, to December 31, 2024. The number of tramadol prescriptions was quantified quarterly and compared to the total number of opioid prescriptions (including tramadol) during the same period. No identifiable patient information was collected. Results: A total of 17,660 tramadol prescriptions were written in 2024. Quarterly breakdowns were: Q1 \u2013 4,347; Q2 \u2013 4,382; Q3 \u2013 4,369; Q4 \u2013 4,562. Overall, tramadol prescriptions accounted for 25.9% of the 68,212 total opioid prescriptions written during the year. Conclusion: Tramadol constituted over one-quarter of all opioid prescriptions in this academic medical center. Prescribing remained stable across all quarters, with a slight increase observed in Q4. These findings highlight tramadol\u2019s significant role in opioid prescribing practices for acute and chronic pain management. Psychopharmacology Bulletin. 2026;56(1):64\u201370.<\/jats:p>","DOI":"10.64719\/pb.15421","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:38:16Z","timestamp":1767976696000},"page":"64-70","source":"Crossref","is-referenced-by-count":1,"title":["Tramadol Utilization Patterns: A One-Year Retrospective Review"],"prefix":"10.64719","volume":"56","author":[{"given":"Jamal","family":"Hasoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvinh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Urits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879\u2013923. doi: 10.2165\/00003088-200443130-00004.","DOI":"10.2165\/00003088-200443130-00004"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Barakat A. Revisiting tramadol: a multi-modal agent for pain management. CNS Drugs. 2019;33(5):481\u2013501. doi: 10.1007\/s40263-019-00623-5.","DOI":"10.1007\/s40263-019-00623-5"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Bravo L, Mico JA, Berrocoso E. Discovery and development of tramadol for the treatment of pain. Expert Opin Drug Discov. 2017;12(12):1281\u20131291. doi: 10.1080\/17460441.2017.1377697. Epub 2017 Sep 17.","DOI":"10.1080\/17460441.2017.1377697"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Vorsanger GJ, Xiang J, Gana TJ, Pascual ML, Fleming RR. Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag. 2008;4(2):87\u201397. doi: 10.5055\/jom.2008.0013.","DOI":"10.5055\/jom.2008.0013"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Baker WF, Mehta N, Riebesell SA, DeBernardis DA, Austin LS. Tramadol-based multimodal pain protocols after arthroscopic rotator cuff repair are similarly effective as oxycodone-based protocols with fewer morphine milligram equivalents prescribed and lower risk of refills. J Orthop. 2025;67:126\u2013131. doi: 10.1016\/j.jor.2025.01.015.","DOI":"10.1016\/j.jor.2025.01.015"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Malik A, Brown Z, Ryder A et al. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) for treatment of fibromyalgia: a comprehensive clinical review. Psychopharmacol Bull. 2025;55(2):24\u201340.","DOI":"10.64719\/pb.4519"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Cao Z, Han K, Lu H et al. Paracetamol combination therapy for back pain and osteoarthritis: a systematic review and meta-analyses. Drugs. 2024;84(8):953\u2013967. doi: 10.1007\/s40265-024-02065-w. Epub 2024 Jun 28.","DOI":"10.1007\/s40265-024-02065-w"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Bustam A, Poh K, Zambri A et al. Subcutaneous versus intravenous tramadol for extremity injury with moderate pain in the emergency department: a randomised controlled noninferiority trial. Eur J Emerg Med. 2023;30(5):331\u2013340. doi: 10.1097\/MEJ.0000000000001047. Epub 2023 Jun 5.","DOI":"10.1097\/MEJ.0000000000001047"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wu YWK, Mitchell DJ. Tramadol as a patient-initiated component of multimodal pain management: a pilot study of 364 lower limb arthroplasty cases. ANZ J Surg. 2023;93(9):2112\u20132118. doi: 10.1111\/ans.18361. Epub 2023 Mar 16.","DOI":"10.1111\/ans.18361"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"April KT, Bisaillon J, Welch V et al. Tramadol for osteoarthritis. Cochrane Database Syst Rev. 2019;5(5):CD005522. doi: 10.1002\/14651858.CD005522.pub3.","DOI":"10.1002\/14651858.CD005522.pub3"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Duehmke RM, Derry S, Wiffen PJ, Bell RF, Aldington D, Moore RA. Tramadol for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6(6):CD003726. doi: 10.1002\/14651858.CD003726.pub4.","DOI":"10.1002\/14651858.CD003726.pub4"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18(4):395\u2013400.","DOI":"10.36076\/ppj.2015\/18\/395"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Vazzana M, Andreani T, Fangueiro J et al. Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems. Biomed Pharmacother. 2015;70:234\u2013238. doi: 10.1016\/j.biopha.2015.01.022. Epub 2015 Feb 7.","DOI":"10.1016\/j.biopha.2015.01.022"},{"key":"ref14","unstructured":"Schug SA. The role of tramadol in current treatment strategies for musculoskeletal pain. Ther Clin Risk Manag. 2007;3(5):717\u2013723."},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Imamura T. Significant efficacy of tramadol\/acetaminophen in elderly patients with chronic low back pain uncontrolled by NSAIDs: an observational study. Open Orthop J. 2015;9:120\u2013125. doi: 10.2174\/1874325001509010120.","DOI":"10.2174\/1874325001509010120"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Arbaiza D, Vidal O. Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study. Clin Drug Investig. 2007;27(1):75\u201383. doi: 10.2165\/00044011-200727010-00007.","DOI":"10.2165\/00044011-200727010-00007"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Leppert W, \u0141uczak J. The role of tramadol in cancer pain treatment\u2014a review. Support Care Cancer. 2005;13(1):5\u201317. doi: 10.1007\/s00520-004-0720-4. Epub 2004 Nov 18.","DOI":"10.1007\/s00520-004-0720-4"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Besic N, Smrekar J, Strazisar B. Acute pain and side effects after tramadol in breast cancer patients: results of a prospective double-blind randomized study. Sci Rep. 2020;10(1):18766. doi: 10.1038\/s41598-020-75961-2.","DOI":"10.1038\/s41598-020-75961-2"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Green JL, Dailey-Govoni T, Butler SF. Real-world data on nonmedical use of tramadol from patients evaluated for substance abuse treatment in the NAVIPPRO Addiction Severity Index-Multimedia Version (ASI-MV\u00ae) network. Drug Saf. 2021;44(2):235\u2013244. doi: 10.1007\/s40264-020-01012-4. Epub 2020 Nov 11.","DOI":"10.1007\/s40264-020-01012-4"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Hassamal S, Miotto K, Dale W, Danovitch I. Tramadol: understanding the risk of serotonin syndrome and seizures. Am J Med. 2018;131(11):1382.e1\u20131382.e6. doi: 10.1016\/j.amjmed.2018.04.025. Epub 2018 May 10.","DOI":"10.1016\/j.amjmed.2018.04.025"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Hasoon J, Chitneni A, Viswanath O, Urits I, Imani F, Varrassi G. Trends in outpatient buprenorphine prescribing for chronic pain: a retrospective analysis over 18 months. Psychopharmacol Bull. 2025;55(3):8\u201319.","DOI":"10.64719\/pb.4529"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Cerda IH, Jung H, Guerrero MC et al. Trends in celecoxib prescribing: a single institution 16-month review. J Clin Med. 2025;14(8):2823. doi: 10.3390\/jcm14082823.","DOI":"10.3390\/jcm14082823"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Hasoon J, Qadeer A, Chen GH, Viswanath O, Urits I, Robinson CL. Methadone prescribing patterns at a single institution: a retrospective study and clinical implications. Psychopharmacol Bull. 2025;55(4):43\u201354.","DOI":"10.64719\/pb.4548"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Tran RT, Patil AS, Nguyen PP et al. Prescribing patterns of gabapentinoids in chronic pain management: a single institution retrospective chart review. Psychopharmacol Bull. 2025;55(1):26\u201336.","DOI":"10.64719\/pb.4510"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:36:09Z","timestamp":1791315369000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/tramadol-utilization-patterns-a-one-year-retrospective-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.15421","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}